Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?

Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?

Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in endocrinology (Lausanne) 2016-05, Vol.7, p.48-48
1. Verfasser: Knobel, Meyer
Format: Artikel
Sprache:eng
Schlagworte:
Endocrinology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 48
container_issue
container_start_page 48
container_title Frontiers in endocrinology (Lausanne)
container_volume 7
creator Knobel, Meyer
description Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular non-toxic benign goiters.
doi_str_mv 10.3389/fendo.2016.00048
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4876491</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1793212912</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-8607755d950f1ef98b6f6e0877330db4b3e553533292a3237145528cd5b5b53e3</originalsourceid><addsrcrecordid>eNpVUctOwzAQtBAIUOHOCfnIJcWP2IkvICivSjwOFHG0nGRNjVIb7ATB35NCQaA97Eo7MzvaQWiPkjHnpTq04JswZoTKMSEkL9fQNpUyzxhXbP3PvIV2U3omSwyhSpWbaIsVLGdSqm10_zh39RxPE-7mgKcNmBbPIphuAb7DNkR8Ct49eXzmrO0TYOMbfNO3nfOh6VsT8W3w2Sy8uxpfBtdBTMc7aMOaNsHuqo_Qw8X5bHKVXd9dTicn11nNleyyUpKiEKJRglgKVpWVtBJIWRSck6bKKw5CcME5U8xwxguaC8HKuhHVUBz4CB1967701QKaenAcTatfoluY-KGDcfr_xru5fgpvOi8LmSs6CBysBGJ47SF1euFSDW1rPIQ-aVoozihTlA1Q8g2tY0gpgv09Q4lexqG_4tDLOPRXHANl_6-9X8LP8_knADuGBA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1793212912</pqid></control><display><type>article</type><title>Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?</title><source>Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Knobel, Meyer</creator><creatorcontrib>Knobel, Meyer</creatorcontrib><description>Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular non-toxic benign goiters.</description><identifier>ISSN: 1664-2392</identifier><identifier>EISSN: 1664-2392</identifier><identifier>DOI: 10.3389/fendo.2016.00048</identifier><identifier>PMID: 27242669</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Endocrinology</subject><ispartof>Frontiers in endocrinology (Lausanne), 2016-05, Vol.7, p.48-48</ispartof><rights>Copyright © 2016 Knobel. 2016 Knobel</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-8607755d950f1ef98b6f6e0877330db4b3e553533292a3237145528cd5b5b53e3</citedby><cites>FETCH-LOGICAL-c396t-8607755d950f1ef98b6f6e0877330db4b3e553533292a3237145528cd5b5b53e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876491/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876491/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27242669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Knobel, Meyer</creatorcontrib><title>Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?</title><title>Frontiers in endocrinology (Lausanne)</title><addtitle>Front Endocrinol (Lausanne)</addtitle><description>Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular non-toxic benign goiters.</description><subject>Endocrinology</subject><issn>1664-2392</issn><issn>1664-2392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVUctOwzAQtBAIUOHOCfnIJcWP2IkvICivSjwOFHG0nGRNjVIb7ATB35NCQaA97Eo7MzvaQWiPkjHnpTq04JswZoTKMSEkL9fQNpUyzxhXbP3PvIV2U3omSwyhSpWbaIsVLGdSqm10_zh39RxPE-7mgKcNmBbPIphuAb7DNkR8Ct49eXzmrO0TYOMbfNO3nfOh6VsT8W3w2Sy8uxpfBtdBTMc7aMOaNsHuqo_Qw8X5bHKVXd9dTicn11nNleyyUpKiEKJRglgKVpWVtBJIWRSck6bKKw5CcME5U8xwxguaC8HKuhHVUBz4CB1967701QKaenAcTatfoluY-KGDcfr_xru5fgpvOi8LmSs6CBysBGJ47SF1euFSDW1rPIQ-aVoozihTlA1Q8g2tY0gpgv09Q4lexqG_4tDLOPRXHANl_6-9X8LP8_knADuGBA</recordid><startdate>20160523</startdate><enddate>20160523</enddate><creator>Knobel, Meyer</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160523</creationdate><title>Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?</title><author>Knobel, Meyer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-8607755d950f1ef98b6f6e0877330db4b3e553533292a3237145528cd5b5b53e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knobel, Meyer</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Frontiers in endocrinology (Lausanne)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knobel, Meyer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?</atitle><jtitle>Frontiers in endocrinology (Lausanne)</jtitle><addtitle>Front Endocrinol (Lausanne)</addtitle><date>2016-05-23</date><risdate>2016</risdate><volume>7</volume><spage>48</spage><epage>48</epage><pages>48-48</pages><issn>1664-2392</issn><eissn>1664-2392</eissn><abstract>Patients with large benign goiters often present local compressive symptoms that require surgical treatment, including dysphagia, neck tightness, and airway obstruction. In contrast, patients with such goiters who remain asymptomatic may be observed after exclusion of malignancy. The use of levothyroxine (LT4) to reduce the volume of the goiter is still a controversial treatment for large goiters, and the optimal surgical procedure for multinodular goiter is still debatable. Radioiodine is a safe and effective treatment option when used alone or in combination with recombinant human TSH. This review discusses current therapeutic options to treat diffuse and multinodular non-toxic benign goiters.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>27242669</pmid><doi>10.3389/fendo.2016.00048</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-2392
ispartof Frontiers in endocrinology (Lausanne), 2016-05, Vol.7, p.48-48
issn 1664-2392
1664-2392
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4876491
source Directory of Open Access Journals; PubMed Central Open Access; PubMed Central; EZB Electronic Journals Library
subjects Endocrinology
title Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T23%3A21%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Which%20Is%20the%20Ideal%20Treatment%20for%20Benign%20Diffuse%20and%20Multinodular%20Non-Toxic%20Goiters?&rft.jtitle=Frontiers%20in%20endocrinology%20(Lausanne)&rft.au=Knobel,%20Meyer&rft.date=2016-05-23&rft.volume=7&rft.spage=48&rft.epage=48&rft.pages=48-48&rft.issn=1664-2392&rft.eissn=1664-2392&rft_id=info:doi/10.3389/fendo.2016.00048&rft_dat=%3Cproquest_pubme%3E1793212912%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1793212912&rft_id=info:pmid/27242669&rfr_iscdi=true